Comparison of ESC and ACCF/AHA Guidelines for Oral Antiplatelet Treatment in the Management of Patients with Acute Coronary Syndrome
Yükleniyor...
Dosyalar
Tarih
2016
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Emergency Medicine Physicians Assoc Turkey
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Basically, acute coronary syndrome (ACS) is caused by the partial or total occlusion of coronary arteries because of platelet activation and aggregation. Hence, one of the major components of ACS treatment is the inhibition of platelet activation and aggregation. New studies performed in recent years have led to the update of guidelines for the usage of antiplatelet agents (APA) in the treatment of ACSs. This paper aims to compare the European Society of Cardiology (ESC) and American Heart Association (ACCF/AHA) guidelines, by summarizing the key points, regarding the usage of oral APA in patients admitted to emergency departments due to ACS.
Açıklama
WOS: 000382873800007
Anahtar Kelimeler
Acute coronary syndrome, recommendations, aspirin, prasugrel, ticagrelor, clopidogrel
Kaynak
Eurasian Journal Of Emergency Medicine
WoS Q Değeri
N/A
Scopus Q Değeri
Cilt
15
Sayı
3
